Patent details

Basic Information

Publication number:

EP2709610

PCT Application Number:

PCT/US/2012/038663

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127259505

PCT Publication Number:

WO/2012/159064

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

HIGH CONCENTRATION OLOPATADINE OPHTHALMIC COMPOSITION

French Title of Invention:

COMPOSITION OPHTALMIQUE À CONCENTRATION ÉLEVÉE EN OLOPATADINE

German Title of Invention:

HOCHKONZENTRIERTE OPHTHALMISCHE OLOPATADINZUSAMMENSETZUNG

SPC Number:

Dates

Filing date:

18/05/2012

Grant date:

18/05/2016

EP Publication Date:

18/05/2016

PCT Publication Date:

22/11/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/03/2014

EP B1 Publication Date:

18/05/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/05/2016

Expiration date:

18/05/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/08/2016

 

 

Name:

NOVARTIS AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

GALÁN Francisco Javier

Address:

Spain (ES)

2

Name:

PERDIGUER Núria

Address:

Spain (ES)

3

Name:

GHOSH Malay

Address:

United States (US)

4

Name:

ALANI Laman

Address:

United States (US)

5

Name:

SINGH Onkar

Address:

United States (US)

6

Name:

GAMACHE Daniel A.

Address:

United States (US)

Priority

1

Priority Number:

201161487789

Priority Date:

19/05/2011

Priority Country:

United States (US)

2

Priority Number:

201161548957

Priority Date:

19/10/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/335;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages